Stay updated on Safe Doses CX-188 in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.

Latest updates to the Safe Doses CX-188 in Solid Tumors Clinical Trial page
- ChecktodayChange DetectedThe page revision label was updated from v3.5.3 to v3.5.4, indicating a small platform update. This update does not change the study details displayed.SummaryDifference0.1%

- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check22 days agoChange DetectedThe page’s displayed software/site revision was updated from v3.5.2 to v3.5.3 without changing the underlying study details.SummaryDifference0.1%

- Check29 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2; no visible content or functionality changes.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the site.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision label changes from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check94 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2, indicating a minor UI update; no observable changes to study details or data.SummaryDifference0.1%

Stay in the know with updates to Safe Doses CX-188 in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safe Doses CX-188 in Solid Tumors Clinical Trial page.